BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

381 related articles for article (PubMed ID: 15970166)

  • 1. [Prevalences of hepatitis virus coinfection and indications for chronic hepatitis C virus treatment and liver transplantation in Spanish HIV-infected patients. The GESIDA 29/02 and FIPSE 12185/01 Multicenter Study].
    González-García JJ; Mahillo B; Hernández S; Pacheco R; Diz S; García P; Esteban H; Arribas JR; Quereda C; Rubio R; Díez J; Moreno S; Vázquez-Rodríguez JJ
    Enferm Infecc Microbiol Clin; 2005; 23(6):340-8. PubMed ID: 15970166
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence and clinical relevance of occult hepatitis B in the fibrosis progression and antiviral response to INF therapy in HIV-HCV-coinfected patients.
    Laguno M; Larrousse M; Blanco JL; Leon A; Milinkovic A; Martínez-Rebozler M; Loncá M; Martinez E; Sanchez-Tapias JM; de Lazzari E; Gatell JM; Costa J; Mallolas J
    AIDS Res Hum Retroviruses; 2008 Apr; 24(4):547-53. PubMed ID: 18393687
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Seroprevalence of hepatitis virus infection in men who have sex with men aged 18-40 years in Taiwan.
    Tseng YT; Sun HY; Chang SY; Wu CH; Liu WC; Wu PY; Lu CL; Hsieh CY; Hung CC
    J Formos Med Assoc; 2012 Aug; 111(8):431-8. PubMed ID: 22939661
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Significance of hepatitis B core antibody as the only marker of hepatitis B infection].
    Colomina-Rodríguez J; González-García D; Burgos-Teruel A; Fernández-Lorenz N; Guerrero-Espejo A
    Enferm Infecc Microbiol Clin; 2005 Feb; 23(2):80-5. PubMed ID: 15743579
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Profile of patients triply infected with HIV and the hepatitis B and C viruses in the HAART era.
    Maida I; Ríos MJ; Pérez-Saleme L; Ramos B; Soriano V; Pegram PS; Mura MS; Sánchez-Margalet V; Saldívar-Cornejo I; Wilkin A; Babudieri S; Núñez M
    AIDS Res Hum Retroviruses; 2008 May; 24(5):679-83. PubMed ID: 18462085
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of hepatitis viruses in an anti-human immunodeficiency virus-positive population from Argentina. A multicentre study.
    Fainboim H; González J; Fassio E; Martínez A; Otegui L; Eposto M; Cahn P; Marino R; Landeira G; Suaya G; Gancedo E; Castro R; Brajterman L; Laplumé H
    J Viral Hepat; 1999 Jan; 6(1):53-7. PubMed ID: 10847130
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Recommendations of Gesida/PNS/AEEH for the management and treatment of the adult patient co-infected with HIV and hepatitis A, B and C virus].
    Panel de expertos de Gesida, Secretaría del Plan Nacional sobre el Sida (SPNS) y Asociación Española para el Estudio del Hígado (AEEH)
    Enferm Infecc Microbiol Clin; 2010 Jan; 28(1):31.e1-31. PubMed ID: 20116629
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of hepatitis E infection in HIV/HCV-coinfected patients in Spain (2012-2014).
    Vázquez-Morón S; Berenguer J; González-García J; Jiménez-Sousa MÁ; Canorea I; Guardiola JM; Crespo M; Quereda C; Sanz J; Carrero A; Hontañón V; Avellón A; Resino S
    Sci Rep; 2019 Feb; 9(1):1143. PubMed ID: 30718554
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatitis A, B, C and HIV seroprevalence among Syrian refugee children admitted to outpatient clinics.
    Köse Ş; Ödemiş I; Çelik D; Gireniz Tatar B; Akbulut I; Çiftdoğan DY
    Infez Med; 2017 Dec; 25(4):339-343. PubMed ID: 29286012
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characteristics of dual infection of hepatitis B and C viruses among patients with chronic liver disease: a study from tertiary care hospital.
    Chakravarti A; Verma V; Jain M; Kar P
    Trop Gastroenterol; 2005; 26(4):183-7. PubMed ID: 16737047
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Viral hepatitis and HIV infection among injection drug users in a central Iranian City.
    Sofian M; Aghakhani A; Banifazl M; Azadmanesh K; Farazi AA; McFarland W; Eslamifar A; Ramezani A
    J Addict Med; 2012 Dec; 6(4):292-6. PubMed ID: 22895463
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HBV reactivation in patients with HCV/HBV cirrhosis on treatment with direct-acting antivirals.
    Calvaruso V; Ferraro D; Licata A; Bavetta MG; Petta S; Bronte F; Colomba G; Craxì A; Di Marco V
    J Viral Hepat; 2018 Jan; 25(1):72-79. PubMed ID: 28703895
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatitis B virus and hepatitis C virus dual infection among patients with chronic liver disease.
    Saravanan S; Velu V; Nandakumar S; Madhavan V; Shanmugasundaram U; Murugavel KG; Balakrishnan P; Kumarasamy N; Solomon S; Thyagarajan SP
    J Microbiol Immunol Infect; 2009 Apr; 42(2):122-8. PubMed ID: 19597643
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rates of sustained virological response 12 weeks after the scheduled end of direct-acting antiviral (DAA)-based hepatitis C virus (HCV) therapy from the National German HCV registry: does HIV coinfection impair the response to DAA combination therapy?
    Bischoff J; Mauss S; Cordes C; Lutz T; Scholten S; Moll A; Jäger H; Cornberg M; Manns MP; Baumgarten A; Rockstroh JK
    HIV Med; 2018 Apr; 19(4):299-307. PubMed ID: 29368456
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Single (B or C), dual (BC or BD) and triple (BCD) viral hepatitis in HIV-infected patients in Madrid, Spain.
    Arribas JR; González-García JJ; Lorenzo A; Montero D; Ladrón de Guevara C; Montes M; Hernández S; Pacheco R; Peña JM; Vázquez JJ
    AIDS; 2005 Sep; 19(13):1361-5. PubMed ID: 16103766
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The burden of HBV infection in HCV patients in Italy and the risk of reactivation under DAA therapy.
    Stroffolini T; Sagnelli E; Sagnelli C; Smedile A; Furlan C; Morisco F; Coppola N; Andriulli A; Almasio PL
    Dig Liver Dis; 2019 Mar; 51(3):434-437. PubMed ID: 30361062
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Viral co-infections in hepatitis C: HBV, HBV-C/HGV and TTV studies].
    Pár A; Takács M; Brojnás J; Berencsi G; Paál M; Horányi M; Miseta A; Hegedüs G; Mózsik G; Hunyady B
    Orv Hetil; 2004 May; 145(19):987-92. PubMed ID: 15181733
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of HIV and hepatitis virus coinfection.
    Mendes-Corrêa M; Núñez M
    Expert Opin Pharmacother; 2010 Oct; 11(15):2497-516. PubMed ID: 20629586
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coinfection of Schistosoma Species with Hepatitis B or Hepatitis C Viruses.
    Abruzzi A; Fried B; Alikhan SB
    Adv Parasitol; 2016; 91():111-231. PubMed ID: 27015949
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Seroprevalence of hepatitis and HIV infection among rural pregnant women in Cameroon.
    Ndumbe PM; Skalsky J; Joller-Jemelka HI
    APMIS; 1994 Sep; 102(9):662-6. PubMed ID: 7524547
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.